Stockreport

SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF develop potential antibody treatments for Alzheimer's disease, ?the biotech firm said on Monday. Under the agreement, SciNeuro will receive $165 million upfront ?and c [Read more]